Current Knowledge of Vaccinations in Chronic Kidney Disease Patients

被引：25
作者：
Haddiya, Intissar [1 ]
机构：
[1] Univ Mohamed Premier, Fac Med & Pharm Oujda, Lab Epidemiol Clin Res & Publ Hlth, Dept Nephrol, 12 Ave Ouafae, Hay Alhikma 60050, Oujda, Morocco
来源：
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE | 2020年 / 13卷
关键词：
immunizations; vaccines; immune system; chronic kidney disease; dialysis; kidney transplant; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; HEPATITIS-B; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; UNITED-STATES; HEMODIALYSIS-PATIENTS; CONJUGATE VACCINE; VIRUS-INFECTION; RECOMMENDATIONS; STAGE;
D O I：
10.2147/IJNRD.S231142
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Chronic kidney disease (CKD) patients are at high risk for infectious complications. This is partly due to their dysfunctional immune system, especially in advanced CKD stages. Vaccination represents an important prevention strategy in these patients, as several studies have reported lower infection rates and significantly reduced morbidity and mortality in hospitals adopting vaccination protocols. However, vaccination rates are particularly low in these patients, and the diminished immune responsiveness remains the main issue of vaccination in CKD patients. Besides, there are various immunization protocols across the world in the absence of optimal vaccination policies. This paper aims to discuss the current knowledge of vaccination in this immunocompromised group of patients based on recent evidence and recommendations.
引用
收藏
页码：179 / 185
页数：7
相关论文
共 59 条
[1]   The influence of uraemia and haemodialysis on neutrophil phagocytosis and antimicrobial killing [J].
Anding, K ;
Gross, P ;
Rost, JM ;
Allgaier, D ;
Jacobs, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :2067-2073
[2]   Vaccination Rates among the General Adult Population and High-Risk Groups in the United States [J].
Annunziata, Kathy ;
Rak, Aaron ;
Del Buono, Heather ;
DiBonaventura, Marco ;
Krishnarajah, Girishanthy .
PLOS ONE, 2012, 7 (11)
[3]   A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B) (Reprinted from The Medical Letter on Drugs and Therapeutics vol 60, pg 17-18, 2018) [J].
Abramowicz, Mark ;
Zuccotti, Gianna ;
Pflomm, Jean-Marie .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (08) :822-+
[4]  
[Anonymous], 2012, GUIDELINES VACCINATI
[5]  
Banatvala J, 2000, LANCET, V355, P561, DOI 10.1016/S0140-6736(99)07239-6
[6]   Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination [J].
Barraclough, Katherine A. ;
Wiggins, Kathryn J. ;
Hawley, Carmel M. ;
van Eps, Carolyn L. ;
Mudge, David W. ;
Johnson, David W. ;
Whitby, Michael ;
Carpenter, Sally ;
Playford, E. Geoffrey .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (01) :95-103
[7]   Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis [J].
Bazzoni, G ;
Dejana, E .
PHYSIOLOGICAL REVIEWS, 2004, 84 (03) :869-901
[8]  
Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816
[9]   Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies [J].
Bitsori, Maria ;
Galanakis, Emmanouil .
EXPERT REVIEW OF VACCINES, 2015, 14 (10) :1385-1395
[10]   Seasonal influenza vaccine in immunocompromised persons [J].
Bosaeed, Mohammad ;
Kumar, Deepali .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (06) :1311-1322
123456